Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms

Bibliographic Details
Main Authors:	Virginie Lafont, Sophie Lucas, Nathalie Bonnefoy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Immunology
Subjects:	tumor environment immunotherapy immunosuppression regulatory cells tumor escape
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.691899/full

Similar Items

Reverting Immune Suppression to Enhance Cancer Immunotherapy
by: Bella S. Guerrouahen, et al.
Published: (2020-01-01)

Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
by: Gao, R., et al.
Published: (2022)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
by: Samuel I. Kim, et al.
Published: (2021-02-01)

Control of the immune response by proangiogenic factors
by: Thibault eVORON, et al.
Published: (2014-04-01)

Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
by: Nader El-Sayes, et al.
Published: (2021-02-01)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
by: Belzile O, et al.
Published: (2018-01-01)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
by: Julie Giraud, et al.
Published: (2021-03-01)

Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
by: Justyna Błach, et al.
Published: (2021-08-01)

Therapy with CD4+CD25+ T regulatory cells – should we be afraid of cancer?
by: Mateusz Gliwiński, et al.
Published: (2019-04-01)

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody
by: Laetitia They, et al.
Published: (2017-10-01)

Tackling Resistance to Cancer Immunotherapy: What Do We Know?
by: Soehartati A. Gondhowiardjo, et al.
Published: (2020-09-01)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
by: Zaoqu Liu, et al.
Published: (2021-01-01)

Editorial: Targeting Myeloid Cells to Fight Cancer
by: Maija Hollmén, et al.
Published: (2019-12-01)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
by: Geny Piro, et al.
Published: (2019-10-01)

Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
by: Marilina García-Aranda, et al.
Published: (2019-05-01)

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
by: Reem Saleh, et al.
Published: (2020-07-01)

T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
by: Alexandra Kegler, et al.
Published: (2019-09-01)

Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
by: Li Yang, et al.
Published: (2019-11-01)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
by: Simona Sivori, et al.
Published: (2020-09-01)

Improvement of cancer immunotherapy by combining molecular targeted therapy
by: Yutaka eKawakami, et al.
Published: (2013-05-01)

Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth
by: Nada Chaoul, et al.
Published: (2018-03-01)

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
by: Ya-Nan Pi, et al.
Published: (2021-07-01)

Frontiers in Tumor Immunity : Grand Challenge Cancer and Immunity : a family drama
by: Wolf Hervé eFridman, et al.
Published: (2011-08-01)

Tumor-altered dendritic cell function: implications for anti-tumor immunity
by: Kristian Michael Hargadon
Published: (2013-07-01)

Immunotherapy in Head and Neck Squamous Cell Cancer
by: Nerina Denaro, et al.
Published: (2018-12-01)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
by: Yufei Wang, et al.
Published: (2020-09-01)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01)

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
by: Mahmoud S. Alghamri, et al.
Published: (2021-05-01)

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
by: Hawkins ER, et al.
Published: (2021-04-01)

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
by: Alexandre Perrier, et al.
Published: (2020-07-01)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
by: Shan-Shan Yin, et al.
Published: (2020-07-01)

Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
by: Ghita Chabab, et al.
Published: (2020-09-01)

Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity
by: Shingo Kato, et al.
Published: (2018-02-01)

Mechanisms of tumour escape from immune surveillance
by: Lisiecka Urszula, et al.
Published: (2016-12-01)

The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
by: Claudia Galassi, et al.
Published: (2021-09-01)

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
by: Amanda J. Oliver, et al.
Published: (2018-01-01)

Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy
by: Kelly eKersten, et al.
Published: (2015-10-01)

Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination
by: Annkristin Heine, et al.
Published: (2017-08-01)

Myeloid Cell-Derived Arginase in Cancer Immune Response
by: Tomasz M. Grzywa, et al.
Published: (2020-05-01)

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
by: Vincenzo Salemme, et al.
Published: (2021-03-01)